Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maron

Showing results (321-330 of 3,459) with videos related to

Pageof 346
Sort By:
Journal of the American Heart Association|October 8, 2021
Cardiovascular Diseases That Have Emerged From the DarknessBarry J Maron, Martin S Maron, Mathew S Maurer, et al.
The American Journal of Medicine|October 18, 2016
Nonobstructive Hypertrophic Cardiomyopathy Out of the Shadows: Known from the Beginning but Largely Ignored … Until NowBarry J Maron, Ethan J Rowin, Martin S Maron, et al.
European Heart Journal|May 19, 2017
Anatomic validation of late gadolinium enhancement as evidence of myocardial scarring in LAMP2 cardiomyopathyEthan J Rowin, Barry J Maron, Knarik Arkun, et al.
Pacing and Clinical Electrophysiology : PACE|June 13, 2018
Left ventricular apical aneurysm in hypertrophic cardiomyopathy as a risk factor for sudden death at any ageEthan J Rowin, Barry J Maron, Aalap Chokshi, et al.
Journal of the American College of Cardiology|July 11, 2009
The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathyBarry J Maron, Martin S Maron, E Douglas Wigle, et al.
Heart Rhythm|July 28, 2020
Back to the future: Predicting sudden death in hypertrophic cardiomyopathy relying on individual risk markers and physician judgment without mathematical scoringMartin S Maron, John Brush, Ethan J Rowin, et al.
The American Journal of Cardiology|July 1, 2023
Do Implantable Cardioverter-Defibrillators Really Belong on the Athlete Field?Martin S Maron, Ethan J Rowin, Jiri Bonaventura, et al.
Journal of the American Heart Association|June 10, 2023
Is Hypertrophic Cardiomyopathy Always a Familial and Inherited Disease?Jiri Bonaventura, Ethan J Rowin, Martin S Maron, et al.
The American Journal of Medicine|August 2, 2017
Achieving Extended Longevity and Quality of Life for Senior Patients With Hypertrophic Cardiomyopathy: What Is PossibleBarry J Maron, Ethan J Rowin, Martin S Maron, et al.
Journal of the American Heart Association|March 26, 2025
Evidence of Declining Mortality Trends for Hypertrophic Cardiomyopathy in the United States and the Impact of the COVID-19 PandemicAhmed Sayed, Barry J Maron, Ethan J Rowin, et al.
Pageof 346

Showing results (321-330 of 3,459) with videos related to

Sort By:
Pageof 346
Journal of the American Heart Association|October 8, 2021
Cardiovascular Diseases That Have Emerged From the DarknessBarry J Maron, Martin S Maron, Mathew S Maurer, et al.
The American Journal of Medicine|October 18, 2016
Nonobstructive Hypertrophic Cardiomyopathy Out of the Shadows: Known from the Beginning but Largely Ignored … Until NowBarry J Maron, Ethan J Rowin, Martin S Maron, et al.
European Heart Journal|May 19, 2017
Anatomic validation of late gadolinium enhancement as evidence of myocardial scarring in LAMP2 cardiomyopathyEthan J Rowin, Barry J Maron, Knarik Arkun, et al.
Pacing and Clinical Electrophysiology : PACE|June 13, 2018
Left ventricular apical aneurysm in hypertrophic cardiomyopathy as a risk factor for sudden death at any ageEthan J Rowin, Barry J Maron, Aalap Chokshi, et al.
Journal of the American College of Cardiology|July 11, 2009
The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathyBarry J Maron, Martin S Maron, E Douglas Wigle, et al.
Heart Rhythm|July 28, 2020
Back to the future: Predicting sudden death in hypertrophic cardiomyopathy relying on individual risk markers and physician judgment without mathematical scoringMartin S Maron, John Brush, Ethan J Rowin, et al.
The American Journal of Cardiology|July 1, 2023
Do Implantable Cardioverter-Defibrillators Really Belong on the Athlete Field?Martin S Maron, Ethan J Rowin, Jiri Bonaventura, et al.
Journal of the American Heart Association|June 10, 2023
Is Hypertrophic Cardiomyopathy Always a Familial and Inherited Disease?Jiri Bonaventura, Ethan J Rowin, Martin S Maron, et al.
The American Journal of Medicine|August 2, 2017
Achieving Extended Longevity and Quality of Life for Senior Patients With Hypertrophic Cardiomyopathy: What Is PossibleBarry J Maron, Ethan J Rowin, Martin S Maron, et al.
Journal of the American Heart Association|March 26, 2025
Evidence of Declining Mortality Trends for Hypertrophic Cardiomyopathy in the United States and the Impact of the COVID-19 PandemicAhmed Sayed, Barry J Maron, Ethan J Rowin, et al.
Pageof 346